Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ferreri

Showing results (71-80 of 453) with videos related to

Pageof 46
Sort By:
World Journal of Gastroenterology|August 2, 2014
De-escalating therapy in gastric aggressive lymphomaRosanna Cuccurullo, Silvia Govi, Andrés J M Ferreri
Seminars in Cancer Biology|October 5, 2013
Marginal zone lymphomas and infectious agentsAndrés J M Ferreri, Silvia Govi, Maurilio Ponzoni
Clinical Lymphoma, Myeloma & Leukemia|May 16, 2026
SOHO State of the Art Updates and Next Questions | Management of Primary Central Nervous System LymphomaPaolo Fiore, Teresa Calimeri, Andrés J M Ferreri
Best Practice & Research. Clinical Haematology|March 15, 2017
Ocular adnexal marginal zone lymphoma: Clinical presentation, pathogenesis, diagnosis, prognosis, and treatmentMarianna Sassone, Maurilio Ponzoni, Andrés J M Ferreri
The Oncologist|July 10, 2015
Chemoimmunotherapy for Mucosa-Associated Lymphoid Tissue-Type Lymphoma: A Review of the LiteratureBarbara Kiesewetter, Andrés J M Ferreri, Markus Raderer
Expert Review of Neurotherapeutics|April 11, 2018
Challenges and prospects in the diagnosis and treatment of primary central nervous system lymphomaGiovanni Citterio, Teresa Calimeri, Andrés J M Ferreri
Current Opinion in Oncology|August 15, 2013
The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomachAndrés J M Ferreri, Silvia Govi, Maurilio Ponzoni
Tumori|June 30, 1983
Toxic, DNA-damaging and mutagenic activity of epichlorohydrin on human cells cultured in vitroP Perocco, P Rocchi, A M Ferreri, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1983
Induction of diphtheria toxin-resistant mutants in human cells by halogenated compoundsA M Ferreri, P Rocchi, A Capucci, et al.
Critical Reviews in Oncology/Hematology|November 4, 2011
Hepatosplenic gamma-delta T-cell lymphomaAndrés J M Ferreri, Silvia Govi, Stefano A Pileri
Pageof 46

Showing results (71-80 of 453) with videos related to

Sort By:
Pageof 46
World Journal of Gastroenterology|August 2, 2014
De-escalating therapy in gastric aggressive lymphomaRosanna Cuccurullo, Silvia Govi, Andrés J M Ferreri
Seminars in Cancer Biology|October 5, 2013
Marginal zone lymphomas and infectious agentsAndrés J M Ferreri, Silvia Govi, Maurilio Ponzoni
Clinical Lymphoma, Myeloma & Leukemia|May 16, 2026
SOHO State of the Art Updates and Next Questions | Management of Primary Central Nervous System LymphomaPaolo Fiore, Teresa Calimeri, Andrés J M Ferreri
Best Practice & Research. Clinical Haematology|March 15, 2017
Ocular adnexal marginal zone lymphoma: Clinical presentation, pathogenesis, diagnosis, prognosis, and treatmentMarianna Sassone, Maurilio Ponzoni, Andrés J M Ferreri
The Oncologist|July 10, 2015
Chemoimmunotherapy for Mucosa-Associated Lymphoid Tissue-Type Lymphoma: A Review of the LiteratureBarbara Kiesewetter, Andrés J M Ferreri, Markus Raderer
Expert Review of Neurotherapeutics|April 11, 2018
Challenges and prospects in the diagnosis and treatment of primary central nervous system lymphomaGiovanni Citterio, Teresa Calimeri, Andrés J M Ferreri
Current Opinion in Oncology|August 15, 2013
The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomachAndrés J M Ferreri, Silvia Govi, Maurilio Ponzoni
Tumori|June 30, 1983
Toxic, DNA-damaging and mutagenic activity of epichlorohydrin on human cells cultured in vitroP Perocco, P Rocchi, A M Ferreri, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1983
Induction of diphtheria toxin-resistant mutants in human cells by halogenated compoundsA M Ferreri, P Rocchi, A Capucci, et al.
Critical Reviews in Oncology/Hematology|November 4, 2011
Hepatosplenic gamma-delta T-cell lymphomaAndrés J M Ferreri, Silvia Govi, Stefano A Pileri
Pageof 46